Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring

J. T. Flynn, Eduardo Bancalari, R. Bawol, R. Goldberg, J. Cassady, J. Schiffman, William J Feuer, J. Roberts, D. Gillings, E. Sim

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

To determine whether the use of continuous transcutaneous oxygen monitoring (tcPO2) could reduce the incidence of retinopathy of prematurity (ROP) in pre-term infants receiving oxygen therapy, a randomized, prospective trial of constant monitoring using the transcutaneous oxygen monitor versus intermittent monitoring of oxygen was performed on a population of premature infants at very high risk for the development of ROP. Two hundred ninety-six infants were randomly assigned to either a constantly monitored (CM) or standard case (SC) group. CM infants had tcPO2 monitored continuously as long as they required supplemental oxygen, whereas SC infants had tcPO2 monitored only during the more acute state of their illness. Management of both groups was otherwise identical. One hundred one of 148 infants in the CM group and 113 of 148 in the SC group survived. The overall incidence of ROP was 51% in the CM group and 59% in the SC group (no significant difference). In infants over 1000 g birthweight, as the weight increased there was increasing risk of developing ROP in the SC group. The odds ratio for the ROPsc:ROPcm reached 7.6 in infants between 1200 and 1300 g in infants with Apgar scores greater than or equal to 8 at 5 minutes. The incidence of cicatricial ROP was similar in both groups: four in the CM and five in the SC group.

Original languageEnglish
Pages (from-to)630-638
Number of pages9
JournalOphthalmology
Volume94
Issue number6
StatePublished - Aug 6 1987

Fingerprint

Retinopathy of Prematurity
Oxygen
Incidence
Apgar Score
Premature Infants
Odds Ratio
Weights and Measures

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Flynn, J. T., Bancalari, E., Bawol, R., Goldberg, R., Cassady, J., Schiffman, J., ... Sim, E. (1987). Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring. Ophthalmology, 94(6), 630-638.

Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring. / Flynn, J. T.; Bancalari, Eduardo; Bawol, R.; Goldberg, R.; Cassady, J.; Schiffman, J.; Feuer, William J; Roberts, J.; Gillings, D.; Sim, E.

In: Ophthalmology, Vol. 94, No. 6, 06.08.1987, p. 630-638.

Research output: Contribution to journalArticle

Flynn, JT, Bancalari, E, Bawol, R, Goldberg, R, Cassady, J, Schiffman, J, Feuer, WJ, Roberts, J, Gillings, D & Sim, E 1987, 'Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring', Ophthalmology, vol. 94, no. 6, pp. 630-638.
Flynn JT, Bancalari E, Bawol R, Goldberg R, Cassady J, Schiffman J et al. Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring. Ophthalmology. 1987 Aug 6;94(6):630-638.
Flynn, J. T. ; Bancalari, Eduardo ; Bawol, R. ; Goldberg, R. ; Cassady, J. ; Schiffman, J. ; Feuer, William J ; Roberts, J. ; Gillings, D. ; Sim, E. / Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring. In: Ophthalmology. 1987 ; Vol. 94, No. 6. pp. 630-638.
@article{5224cab8973c4ac894ba74188b91603a,
title = "Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring",
abstract = "To determine whether the use of continuous transcutaneous oxygen monitoring (tcPO2) could reduce the incidence of retinopathy of prematurity (ROP) in pre-term infants receiving oxygen therapy, a randomized, prospective trial of constant monitoring using the transcutaneous oxygen monitor versus intermittent monitoring of oxygen was performed on a population of premature infants at very high risk for the development of ROP. Two hundred ninety-six infants were randomly assigned to either a constantly monitored (CM) or standard case (SC) group. CM infants had tcPO2 monitored continuously as long as they required supplemental oxygen, whereas SC infants had tcPO2 monitored only during the more acute state of their illness. Management of both groups was otherwise identical. One hundred one of 148 infants in the CM group and 113 of 148 in the SC group survived. The overall incidence of ROP was 51{\%} in the CM group and 59{\%} in the SC group (no significant difference). In infants over 1000 g birthweight, as the weight increased there was increasing risk of developing ROP in the SC group. The odds ratio for the ROPsc:ROPcm reached 7.6 in infants between 1200 and 1300 g in infants with Apgar scores greater than or equal to 8 at 5 minutes. The incidence of cicatricial ROP was similar in both groups: four in the CM and five in the SC group.",
author = "Flynn, {J. T.} and Eduardo Bancalari and R. Bawol and R. Goldberg and J. Cassady and J. Schiffman and Feuer, {William J} and J. Roberts and D. Gillings and E. Sim",
year = "1987",
month = "8",
day = "6",
language = "English",
volume = "94",
pages = "630--638",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring

AU - Flynn, J. T.

AU - Bancalari, Eduardo

AU - Bawol, R.

AU - Goldberg, R.

AU - Cassady, J.

AU - Schiffman, J.

AU - Feuer, William J

AU - Roberts, J.

AU - Gillings, D.

AU - Sim, E.

PY - 1987/8/6

Y1 - 1987/8/6

N2 - To determine whether the use of continuous transcutaneous oxygen monitoring (tcPO2) could reduce the incidence of retinopathy of prematurity (ROP) in pre-term infants receiving oxygen therapy, a randomized, prospective trial of constant monitoring using the transcutaneous oxygen monitor versus intermittent monitoring of oxygen was performed on a population of premature infants at very high risk for the development of ROP. Two hundred ninety-six infants were randomly assigned to either a constantly monitored (CM) or standard case (SC) group. CM infants had tcPO2 monitored continuously as long as they required supplemental oxygen, whereas SC infants had tcPO2 monitored only during the more acute state of their illness. Management of both groups was otherwise identical. One hundred one of 148 infants in the CM group and 113 of 148 in the SC group survived. The overall incidence of ROP was 51% in the CM group and 59% in the SC group (no significant difference). In infants over 1000 g birthweight, as the weight increased there was increasing risk of developing ROP in the SC group. The odds ratio for the ROPsc:ROPcm reached 7.6 in infants between 1200 and 1300 g in infants with Apgar scores greater than or equal to 8 at 5 minutes. The incidence of cicatricial ROP was similar in both groups: four in the CM and five in the SC group.

AB - To determine whether the use of continuous transcutaneous oxygen monitoring (tcPO2) could reduce the incidence of retinopathy of prematurity (ROP) in pre-term infants receiving oxygen therapy, a randomized, prospective trial of constant monitoring using the transcutaneous oxygen monitor versus intermittent monitoring of oxygen was performed on a population of premature infants at very high risk for the development of ROP. Two hundred ninety-six infants were randomly assigned to either a constantly monitored (CM) or standard case (SC) group. CM infants had tcPO2 monitored continuously as long as they required supplemental oxygen, whereas SC infants had tcPO2 monitored only during the more acute state of their illness. Management of both groups was otherwise identical. One hundred one of 148 infants in the CM group and 113 of 148 in the SC group survived. The overall incidence of ROP was 51% in the CM group and 59% in the SC group (no significant difference). In infants over 1000 g birthweight, as the weight increased there was increasing risk of developing ROP in the SC group. The odds ratio for the ROPsc:ROPcm reached 7.6 in infants between 1200 and 1300 g in infants with Apgar scores greater than or equal to 8 at 5 minutes. The incidence of cicatricial ROP was similar in both groups: four in the CM and five in the SC group.

UR - http://www.scopus.com/inward/record.url?scp=0023191061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023191061&partnerID=8YFLogxK

M3 - Article

C2 - 3627711

AN - SCOPUS:0023191061

VL - 94

SP - 630

EP - 638

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 6

ER -